Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines.

Somiya, Masaharu; Mine, Sohtaro; Yasukawa, Kosuke; Ikeda, Saki

Somiya, Masaharu; Mine, Sohtaro; Yasukawa, Kosuke; Ikeda, Saki.

Afiliação

Somiya M; The Institute of Scientific and Industrial Research, Osaka University, Mihogaoka 8-1, Ibaraki, Osaka 5670047, Japan. Electronic address: msomiya@sanken.osaka-u.ac.jp.
Mine S; Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 50 South DR, Bethesda, MD 20814, USA.
Yasukawa K; MedStar Washington Hospital Center, DC, United States, 110 Irving Street NW, Washington, DC 20010, USA.
Ikeda S; Department of Pediatrics, Baylor College of Medicine, 1102 Bates Avenue, Houston, TX 77030, USA.

Vaccine ; 39(25): 3313-3314, 2021 06 08.

Article em En | MEDLINE | ID: mdl-34020815

Assuntos

Anafilaxia; COVID-19; Anafilaxia/epidemiologia; Vacinas contra COVID-19; Feminino; Humanos; Incidência; Masculino; RNA Mensageiro; SARS-CoV-2; Caracteres Sexuais

Palavras-chave

Anaphylaxis; COVID-19; Sex difference; mRNA vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Anafilaxia Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Vaccine Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google